You are viewing an incomplete version of our website. Please click to reload the website as full version.

Cell Lysis Buffer

Details for Product No. ABIN412531, Supplier: Log in to see
Application
Sample Preparation (Prep)
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Comment

The Cell Lysis Buffer is optimized for lysis of mammalian cells and tissues for caspase activity assays. The buffer is intended to use as a supplemental reagent for researchers who need to lyse large amount of cells or tissues.

Restrictions For Research Use only
Format Liquid
Storage 4 °C
Expiry Date 12 months
Product cited in: Suda, Itoh, Nakato et al.: "Dimeric combinations of MafB, cFos and cJun control the apoptosis-survival balance in limb morphogenesis." in: Development (Cambridge, England), Vol. 141, Issue 14, pp. 2885-94, 2014 (PubMed).

Hoque, Farooq, Malik et al.: "A novel small-molecule enantiomeric analogue of traditional (-)-morphinans has specific TLR9 antagonist properties and reduces sterile inflammation-induced organ damage." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 190, Issue 8, pp. 4297-304, 2013 (PubMed).

Rui, Zhang, Xu et al.: "Reduction in IL-33 expression exaggerates ischaemia/reperfusion-induced myocardial injury in mice with diabetes mellitus." in: Cardiovascular research, Vol. 94, Issue 2, pp. 370-8, 2012 (PubMed).

Rasbach, Funk, Jayavelu et al.: "5-hydroxytryptamine receptor stimulation of mitochondrial biogenesis." in: The Journal of pharmacology and experimental therapeutics, Vol. 332, Issue 2, pp. 632-9, 2010 (PubMed).

Lu, Verma, Murakami et al.: "Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation." in: Journal of virology, Vol. 83, Issue 14, pp. 7129-41, 2009 (PubMed).

Whitlock, Valbuena, Popov et al.: "Burkholderia mallei cellular interactions in a respiratory cell model." in: Journal of medical microbiology, Vol. 58, Issue Pt 5, pp. 554-62, 2009 (PubMed).

Rasbach, Schnellmann: "Isoflavones promote mitochondrial biogenesis." in: The Journal of pharmacology and experimental therapeutics, Vol. 325, Issue 2, pp. 536-43, 2008 (PubMed).

Ha, Ng, Lamothe et al.: "Mitochondrial proteins Bnip3 and Bnip3L are involved in anthrax lethal toxin-induced macrophage cell death." in: The Journal of biological chemistry, Vol. 282, Issue 36, pp. 26275-83, 2007 (PubMed).

Mohammad, Goustin, Aboukameel et al.: "Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 13, Issue 7, pp. 2226-35, 2007 (PubMed).

Rasbach, Schnellmann: "Signaling of mitochondrial biogenesis following oxidant injury." in: The Journal of biological chemistry, Vol. 282, Issue 4, pp. 2355-62, 2007 (PubMed).

Zeitlin, Joo, Dong et al.: "Antiangiogenic effect of TW37, a small-molecule inhibitor of Bcl-2." in: Cancer research, Vol. 66, Issue 17, pp. 8698-706, 2006 (PubMed).

Takayama, Rogatsky, Schwarcz et al.: "The glucocorticoid receptor represses cyclin D1 by targeting the Tcf-beta-catenin complex." in: The Journal of biological chemistry, Vol. 281, Issue 26, pp. 17856-63, 2006 (PubMed).

Yano, Itoh, Kubota et al.: "A prostacyclin analog prevents radiocontrast nephropathy via phosphorylation of cyclic AMP response element binding protein." in: The American journal of pathology, Vol. 166, Issue 5, pp. 1333-42, 2005 (PubMed).

Ray, Akbiyik, Bernstein et al.: "CD40 engagement prevents peroxisome proliferator-activated receptor gamma agonist-induced apoptosis of B lymphocytes and B lymphoma cells by an NF-kappaB-dependent mechanism." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 174, Issue 7, pp. 4060-9, 2005 (PubMed).

Mohammad, Wang, Aboukameel et al.: "Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-X(L) [(-)-gossypol] against diffuse large cell lymphoma." in: Molecular cancer therapeutics, Vol. 4, Issue 1, pp. 13-21, 2005 (PubMed).

Nowak, Price, Schnellmann: "Lack of a functional p21WAF1/CIP1 gene accelerates caspase-independent apoptosis induced by cisplatin in renal cells." in: American journal of physiology. Renal physiology, Vol. 285, Issue 3, pp. F440-50, 2003 (PubMed).

Kawakami, Kawakami, Puri: "Intratumor administration of interleukin 13 receptor-targeted cytotoxin induces apoptotic cell death in human malignant glioma tumor xenografts." in: Molecular cancer therapeutics, Vol. 1, Issue 12, pp. 999-1007, 2002 (PubMed).

Nowak: "Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells." in: The Journal of biological chemistry, Vol. 277, Issue 45, pp. 43377-88, 2002 (PubMed).

Ghatak, Misra, Toole: "Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway." in: The Journal of biological chemistry, Vol. 277, Issue 41, pp. 38013-20, 2002 (PubMed).

Cummings, Schnellmann: "Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways." in: The Journal of pharmacology and experimental therapeutics, Vol. 302, Issue 1, pp. 8-17, 2002 (PubMed).

Vu, Bortner, Cidlowski: "Differential involvement of initiator caspases in apoptotic volume decrease and potassium efflux during Fas- and UV-induced cell death." in: The Journal of biological chemistry, Vol. 276, Issue 40, pp. 37602-11, 2001 (PubMed).